Speakers

Cristina Antelo, Esq.

Founding Principal and Chief Executive Officer
Ferox Strategies

Scott Biggs

Director, Supplier Services
IQVIA

Andy Bressler, MBA

Managing Director
Bank of America

Scott Cornwell

Chief Executive Officer
Dispensary of Hope

Michael DiFiore, PharmD, MBA

Managing Director
Evercore

Tirzah Duren

President and CEO
American Consumer Institute

Matt Erick

Chief Commercial Officer – Advanced Markets
Biocon Biologics

Robert Foster, JD

Principal Deputy General Counsel and Chief Counsel for Food, Research, and Drugs
U.S. Department of Health and Human Services (HHS)

James Gelfand, JD

President and CEO
The ERISA Industry Committee (ERIC)

Scott Gottlieb, M.D.

Former Commissioner, FDA
Former Senior Advisor, CMS

Keren Haruvi

President of Sandoz US and Head of North America
Sandoz Inc.

Bob Hoffman

AAM Board Chair

Kate Hull

Senior Vice President
Fierce Government Relations

Alex Keeton

Executive Director of the Biosimilars Council
Senior Vice President, Policy, AAM

John Murphy III

President & CEO
AAM

Balaji Prasad, M.D.

Chief Strategy Officer
Alvotech

Giuseppe Randazzo, M.S.

Senior Vice President, Sciences and Regulatory Affairs
AAM

Mark Ratner

Senior Vice President, Government Affairs
AAM

Brian Reid

Founder and Principal, Reid Strategic
Senior Fellow, Tufts’ Center for the Evaluation of Value and Risk in Health

Joseph Shields, Esq.

Chief Executive Officer
Transparency-Rx

Jayson Slotnik, JD, MPH

Partner
Health Policy Strategies, Inc.

Ipsita Smolinski, MBA

Founder/Managing Director
Capitol Street

Maryll Toufanian, JD

Senior Vice President, Regulatory Strategy and Policy
Amneal Pharmaceuticals Inc.

Matt Wetzel, JD

Partner
Goodwin Procter LLP
Skip to content